Chronic hypoxia (CH) is believed to induce myocardial protection, but this is in contrast with clinical evidence. Here, we test the hypothesis that repeated brief reoxygenation episodes during prolonged CH improve myocardial tolerance to hypoxia-induced dysfunction. Male 5-week-old Sprague-Dawley rats (n = 7–9/group) were exposed for 2 weeks to CH (F1O2 = 0.10), intermittent hypoxia (IH, same as CH, but 1 hr/day exposure to room air), or normoxia (N, F1O2 = 0.21). Hearts were isolated, Langendorff perfused for 30 min with hypoxic medium (Krebs-Henseleit, PO2 = 67 mmHg), and exposed to hyperoxia (PO2 = 670 mmHg). CH hearts displayed higher end-diastolic pressure, lower rate-pressure product, and higher vascular resistance than IH. During hypoxic perfusion, anaerobic mechanisms recruitment was similar in CH and IH hearts, but less than in N. Thus, despite differing only for 1 hr daily exposure to room air, CH and IH induced different responses in animal homeostasis, markers of oxidative stress, and myocardial tolerance to reoxygenation. We conclude that the protection in animals exposed to CH appears conferred by the hypoxic preconditioning due to the reoxygenation rather than by hypoxia per se.
McElhinneyDB, WernovskyG.Outcomes of neonates with congenital heart disease. Curr Opin Pediatr13:104–110, 2001.
2.
ImuraH, CaputoM, ParryA, PawadeA, AngeliniGD, SuleimanMS. Age-dependent and hypoxia-related differences in myocardial protection during pediatric open heart surgery. Circulation103:1551–1556, 2001.
LupinettiFM, WareingTH, HuddlestonCB, CollinsJC, BoucekRJ, BenderHW, HammonJW. Pathophysiology of chronic cyanosis in a canine model: functional and metabolic response to global ischemia. J Thorac Cardiovasc Surg90:291–296, 1985.
5.
SilvermanNA, KohlerJ, LevitskyS, PavelDG, FangRB, FeinbergH.Chronic hypoxemia depresses global ventricular function and predisposes the depletion of high-energy phosphates during cardioplegic arrest: implications for surgical repair of cyanotic congenital heart defects. Ann Thorac Surg37:304–308, 1984.
6.
MeersonFZ, GomzakovOA, ShimkovichMV. Adaptation to high altitude hypoxia as a factor preventing development of myocardial ischemic necrosis. Am J Cardiol31:30–34, 1973.
OpieLH, DuchosalF, MoretP.Effects of increased left ventricular work, hypoxia, or coronary ligation on hearts from rats at high altitude. Eur J Clin Invest8:309–315, 1978.
9.
FeldbaumDM, KohmanLJ, VeitLJ. Recovery of hypoxic neonatal hearts after cardioplegic arrest. Cardiovasc Res27:1123–1126, 1993.
10.
TajimaM, KatajoseD, BesshoM, IsoyamaS.Acute ischemic preconditioning and chronic hypoxia independently increase myocardial tolerance to ischemia. Cardiovasc Res28:312–319, 1994.
11.
BakerJE, BoerboomLE, OlingerGN. Tolerance of the developing heart to ischemia: impact of hypoxemia from birth. Am J Physiol268:H1165–H1173, 1995.
12.
FelacoM, GrilliA, GorbunovN, Di NapoliP, De LutiisMA, Di GiulioC, TaccardiAA, BarsottiA, BarbacaneRC, RealeM, ContiP.Endothelial NOS expression and ischemia-reperfusion in isolated working rat heart from hypoxia and hyperoxic conditions. Biochim Biophys Acta1524:203–211, 2000.
13.
SamajaM, MotterliniR, SantoroF, Dell'AntonioG, CornoA.Oxidative injury in reoxygenated and reperfused hearts. Free Rad Biol Med16:255–262, 1994.
14.
SamajaM, CasaliniS, AllibardiS, CornoA, ChierchiaS.Regulation of bioenergetics in O2-limited isolated rat hearts. J Appl Physiol77:2530–2536, 1994.
15.
RoughtonFJW, SeveringhausJW. Accurate determination of O2 dissociation curve of human above 98.7% saturation with data on O2 solubility in unmodified human blood from 0° to 37°C. J Appl Physiol35:861–869, 1973.
16.
SamajaM, AllibardiS, ChierchiaS.Biochemical consequences of electrical pacing in ischemic-reperfused isolated rat hearts. Mol Cell Biochem194:245–249, 1999.
17.
CunninghamMJ, ApsteinCS, WeinbergEO, VogelWM, LorellBH. Influence of glucose and insulin on the exaggerated diastolic and systolic dysfunction of hypertrophied rat hearts during hypoxia. Circ Res66:406–415, 1990.
18.
MilanoG, CornoA, De JongJW, Von SegesserLK, SamajaM.Tolerance of isolated rat hearts to low-flow ischemia and hypoxia of increasing duration: protective role of down-regulation and ATP during ischemia. Mol Cell Biochem226:141–151, 2001.
19.
SamajaM.Blood gas transport at high altitude. Respiration64:422–428, 1997.
20.
ErslevAJ. Humoral regulation of red cell production. Blood8:349–357, 1953.
21.
KayserB, AchesonK, DecombazJ, FernE, CerretelliP.Protein absorption and energy digestibility at high altitude. J Appl Physiol73:2425–2431, 1992.
22.
RabinovitchM, GambleW, NadasAS, MiettinenOS, ReidL.Rat pulmonary circulation after chronic hypoxia: hemodynamic and structural features. Am J Physiol236:818–827, 1979.
23.
KadiiskaMB, GladenBC, BairdDD, DikalovaAE, SohalRS, HatchGE, JonesDP, MasonRP, BarrettJC. Biomarkers of oxidative stress study: are plasma antioxidant markers of CC14 poisoning? Free Rad Biol Med28:838–845, 2000.
24.
LippaS, ColaciccoL, BondaniniF, CallàC, GozzoML, CiccarielloM, AngelittiAG. Plasma levels of coenzyme Q10, vitamin E and lipids in uremic patients on conservative therapy and hemodialysis treatment: some possible biochemical and clinical implications. Clin Chim Acta292:81–91, 2000.
FedurovVV. The concentration and biosynthesis of ubiquinone-9 in the liver of white rats adapted to altitude hypoxia. Biull Eksp Biol Med81:179–181, 1976.
KiharaY, SasayamaS, InokoM, MorganJP. Sodium/calcium exchange modulates intracellular calcium overload during post-hypoxic reoxygenation in mammalian working myocardium. J Clin Invest93:1275–1284, 1994.
29.
BakerJE, HolmanP, KalyanaramanB, GriffithOW, PritchardKA. Adaptation to chronic hypoxia confers tolerance to subsequent myocardial ischemia by increased nitric oxide production. Ann NY Acad Sci874:236–253, 1999.
30.
MontiLD, AllibardiS, PiattiPM, ValsecchiG, CostaS, PozzaG, ChierchiaS, SamajaM.Triglycerides impair postischemic recovery in isolated hearts: roles of endothelin-1 and trimetazidine. Am J Physiol281:H1122–H1130, 2001.
31.
CerretelliP, HoppelerH.Morphologic and metabolic response to chronic hypoxia: the muscle system. In: FreglyMJ, BlatteisCM, Eds. Handbook of Physiology: Section 4: Environmental Physiology. New York:American Physiological Society, Vol II:pp1155–1181, 1996.
32.
RuschitzkaFT, WengerRH, StallmachT, QuaschingT, De WitC, WagnerK, LabuggerR, KelmM, NollG, RulickeT, ShawS, LindbergRLP, RodenwaldB, LutzH, BauerC, LuscherTF, GassmannM.Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin. Proc Natl Acad Sci U S A97:11609–11613, 2000.
33.
BrinesML, GhezziP, KeenanS, AgnelloD, De LanerolleNC, CeramiC, ItriLM, CeramiA.Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci U S A97:10526–10531, 2000.
34.
SakanakaM, WenTC, MatsudaS, MasudaS, MorishitaE, NagaoM, SasakiR.In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci U S A95:4635–4640, 2000.
35.
BakerJE, CurryBD, OlingerGN, GrossGJ. Increased tolerance of the chronically hypoxic immature heart to ischemia: contribution of the KATP channel. Circulation95:1278–1285, 1997.
36.
ZhuangJ, ZhouZ.Protective effects of intermittent hypoxic adaptation on myocardium and its mechanisms. Biol Signals Recept8:316–322, 1999.
37.
PrabhakarN.Physiological and genomic consequences of intermittent hypoxia. Invited review: oxygen sensing during intermittent hypoxia: cellular and molecular mechanisms. J Appl Physiol90:1986–1994, 2001.
